Bioinformatics Course
Seminars
Press Conference
Other Activities
Award
Past Training Programmes
HPV Workshop
Infection Control Course
Systematic Review Workshop
 
 
 
 
Events > HPV Workshop > Programme
2nd ICGEB Workshop on Human papillomavirus: From Basic Biology to Cancer Prevention
 

 
Scientific Programme - Day 1 - 8th Nov 2016
Time Topic Speaker
09:15-09:30 Opening  Ceremony
Opening Lecture
09:30-10:00 The spectrum of HPV-associated clinical problems Paul CHAN, Hong Kong
Session I.a  – Basic Science I
Chairpersons:  Lawrence BANKS, Italy; Martin WONG, Hong Kong
10:00-10:30 The Papillomavirus life cycle at different epithelial sites John DOORBAR, UK
10:30-11:00 HPV virion structure and assembly Robert GARCEA, USA
11:00-11:30 Coffee & poster
Session 1.b – Epidemiology I
Chairpersons:  Ryo KONNO, Japan; Carmen WONG, Hong Kong
11:30-12:00 HPV genotyping - the Korean perspective JS PARK, Korea
12:00-12:30 Cervical cancer prevention: The Taiwan perspective TY CHU, Taiwan
12:30-12:45 Cost-consequences analysis of HPV vaccination in the Hong Kong setting Barry YEUNG, Hong Kong
12:45-13:00 Role of condyloma accuminata in incident HIV infection: a population-based cohort study in Taiwan 2000-2010 Huachun ZOU, China
13:00-14:00 Lunch Symposium
Session 1.c – Cervical Screening
Chairpersons:  MY YU, Hong Kong; YL WOO, Malaysia
14:00-14:30 Cytology and HPV tests – Yin and Yang in cervical cancer screening Annie CHEUNG, Hong Kong
14:30-15:00 Is self-sampling a solution for cervical screening? Eliza WONG, Hong Kong
15:00-15:15 A cross-sectional study on Cobas HPV testing for cervical cancer screening in 11064 Chinese women Qiongyan WU, China
15:15-15:30 Predictive value of three different methods in screening of cervical cancer within 1,111 cases     Xufeng WU, China
15:30-16:00 Coffee & poster
Session 1.d – Translation & Novel Applications
Chairpersons:  TY CHU, Taiwan; SF YIM, Hong Kong
16:00-16:30 Road to eradicating cervical cancer through translational and implementation science YL WOO, Malaysia
16:30-17:00 Translation of HPV mediated immortalization to cancer precision medicine Xuefeng LIU, USA
17:00-17:15 Early prediction of molecular biomarkers for therapy resistance in cervical cancers Lih Wen DENG, Singapore
17:15-17:30 The value of human papillomavirus DNA detection and type 16/18 genotyping by hybrid capture 2 in primary screening for cervical cancer Xiumin ZHAO, China
17:30-17:45 Development of a salivary HPV-16 DNA assay to detect oropharyngeal cancers Chamindie PUNYADEERA, Australia
 
Scientific Programme - Day 2 - 9th Nov 2016
Time Topic Speaker
Session 2.a – Basic Science II
Chairpersons:  Robert GARCEA, USA; John DOORBAR, UK
09:30-10:00 Endosomal sorting pathways and HPV entry mechanisms Lawrence BANKS, Italy
10:00-10:30 HPV and noncoding RNAs Zhi-Ming ZHENG, USA
10:30-10:45 Effect of arecoline on human papillomavirus 16 long control region and oncostain M upregulation by miR-22 suppression Jureeporn CHUERDUANGPHUI, Thailand
10:45-11:00 The HPV-18 E6 oncoprotein regulates CD40 expression via the AT-Hook transcription factor AKNA Joaquin MANZO-MERINO, Mexico
11:00-11:15 Association of human papillomavirus and Epstein-Barr virus infection with gene promoter methylation of O-Methyl guanine methyltransferase in nasopharyngeal carcinoma Nuchsupha SUNTHAMALA, Thailand
11:15-11:30 Coffee & poster
Session 2.b – Epidemiology II
Chairpersons:  Qinjian ZHAO, China; Jo CHEUNG, Hong Kong
11:30-12:00 Cervical cancer screening with HPV testing and cytology in Japan. Trial and early introduction Ryo KONNO, Japan
12:00-12:15 P53 exon 8 codon 282 gene status in human papillomaviruses (HPV)-associated oral squamous cell carcinoma (OSCC) Pensiri PHUSINGHA, Thailand
12:15-12:30 HPV infection- link to oral hygiene? Kai Dun TANG, Australia
12:30-12:45 Salivary biomarkers for detection of human papillomavirus (HPV) - and Epstein-Barr virus (EBV)-related oral squamous cell carcinoma (OSCC) Chukkris HEAWCHAIYAPHUM, Thailand
12:45-13:00 Differential expression of the collagen receptor, DDR1, and collagens Xla1 and VIIIa1 in HPV-negative and -positive oropharyngeal cancer Sook Ling LAI, Malaysia
13:00-14:00 Lunch Symposium
Session 2.c – Vaccine
Chairpersons:  Siaw S BOON, Hong Kong; John DOORBAR, UK
14:00-14:30 Unveiling the neutralizing epitopes of human papillomavirus Qinjian ZHAO, China
14:30-15:00 New approaches to prophylactic HPV vaccines for cervical cancer prevention Robert GARCEA, USA
15:00-15:30 HPV therapeutic vaccine JS PARK, Korea
15:30-16:00 Coffee & poster
Session 2.d – Evolution, classification & variants
Chairpersons:  JS PARK, Korea; Eddy LAM, Hong Kong
16:00-16:30 Human papillomavirus and human migration: partnership of millions years TY CHU, Taiwan
16:30-17:00 Classification & evolution of papillomavirus Zigui CHEN, Hong Kong
17:00-17:30 The Asian HPV 52/58 variants Paul CHAN, Hong Kong
 
Scientific Programme - Day 3 - 10th Nov 2016
Time Topic Speaker
Session 3.a – Basic Science III
Chairpersons: Xuefeng LIU, USA; Zhi-Ming ZHENG, USA
09:30-10:00 The role of HPV E6-PDZ interactions in the development of malignancy Lawrence BANKS, Italy
10:00-10:30 3D tissue models for anti-HPV target discovery and drug validation Thomas BROKER, USA
10:30-10:45 Exosomes from EBV-infected lymphocytes in cervical lesions induced interferon-related gene expression in dendritic cells Sirinart AROMSEREE, Thailand
10:45-11:00 Protein profiling in human cervical keratinocytes transduced with E6D25E of human papillomavirus type 16 Asian variant Peechanika CHOPJITT, Thailand
11:00-11:15 Synergistic effect of E6/E7-specific siRNA with chemotherapeutic agents regulates the dynamics of TP53 and RB/E2F signaling for cell-fate control Nirmal RAJASEKARAN,   South Korea
11:15-11:30 Coffee & poster
Session 3.b – Non-anogenital Lesions
Chairpersons: Zigui CHEN, Hong Kong; Alexander VLANTIS, Hong Kong
11:30-12:00 The prevalence of and factors associated with oral Human Papillomavirus infection: a population-based screening programme Martin WONG, Hong Kong
12:00-12:30 HPV and orophayngeal cancer: the Hong Kong scene Eddy LAM, Hong Kong
12:30-13:00 Presentation of Cutaneous HPV lesions and management of common wart NM LUK, Hong Kong
13:00-13:15 Fanconi anemia and oral human papillomavirus PORTUGAL Magda, Brazil
13:15-14:00 Lunch & poster
Session 3.c – General Cancer Biology
Chairpersons: Thomas BROKER, USA; Alfred CHENG, Hong Kong
14:00-14:30 The role of EBV infection in the pathogenesis of nasopharyngeal carcinoma George TSAO, Hong Kong
14:30-15:00 RNA biology in cancer development Zhi-Ming ZHENG, USA
15:00-15:30 Aurora B is a novel target of human papillomavirus E6 Siaw S BOON, Hong Kong
15:30-15:45 Coffee & poster
Session 3.d – Clinical Practice
Chairpersons: TH CHEUNG, Hong Kong; Xuefeng LIU, USA
15:45-16:15 Human papillomavirus: from bench to bedside and bedside to bench YL WOO, Malaysia
16:15-16:45 True background of HPV vaccine crisis in Japan. Lessons learned for global immunization promotion Ryo KONNO, Japan
16:45-17:15 The development of HPV biomarkers for disease stratification John DOORBAR, UK
17:15-17:30 Characterization of HPV16-E7 binding affibody molecules and tumor specific imaging in HPV16 positive cervical cancer in vivo Lifang ZHANG, China
17:30-17:45 Visualizing transcriptome dynamics of high-risk HPV oncogenes and host genes in cervical malignancies    Kazunori NAGASAKA, Japan
18:30-21:00 Gala Dinner
 
Download Scientific Programme